ADRENALINE (EPINEPHRINE)
adrenaline (epinephrine) 1 in 1000 (1 mg/mL) injection, 5 x 1 mL ampoules
Manner of administration:Injection
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 5 | # of repeats: 1 | DPMQ: $21.43 | Max safety net: $22.91 | General Patient Charge: $25.00 |
| Available brands | |||||
| Link Medical Products Pty Ltd | |||||
adrenaline (epinephrine) 500 microgram/0.3 mL injection, 0.3 mL pen device
Manner of administration:Injection
Restriction
Indication: Acute allergic reaction with anaphylaxis
Treatment phase: Initial sole PBS-subsidised supply for anticipated emergency treatment
Restriction
Indication: Acute allergic reaction with anaphylaxis
Treatment phase: Initial sole PBS-subsidised supply for anticipated emergency treatment
Restriction
Indication: Acute allergic reaction with anaphylaxis
Treatment phase: Continuing sole PBS-subsidised supply for anticipated emergency treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 2 | # of repeats: 0 | DPMQ: $160.50 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Anapen 500 | |||||
adrenaline (epinephrine) 300 microgram/0.3 mL injection, 0.3 mL pen device
Manner of administration:Injection
Restriction
Indication: Acute allergic reaction with anaphylaxis
Treatment phase: Initial sole PBS-subsidised supply for anticipated emergency treatment
Restriction
Indication: Acute allergic reaction with anaphylaxis
Treatment phase: Initial sole PBS-subsidised supply for anticipated emergency treatment
Restriction
Indication: Acute allergic reaction with anaphylaxis
Treatment phase: Continuing sole PBS-subsidised supply for anticipated emergency treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 2 | # of repeats: 0 | DPMQ: $160.50 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
adrenaline (epinephrine) 150 microgram/0.15 mL injection, 0.15 mL pen device
Manner of administration:Injection
Restriction
Indication: Acute allergic reaction with anaphylaxis
Treatment phase: Initial sole PBS-subsidised supply for anticipated emergency treatment
Restriction
Indication: Acute allergic reaction with anaphylaxis
Treatment phase: Initial sole PBS-subsidised supply for anticipated emergency treatment
Restriction
Indication: Acute allergic reaction with anaphylaxis
Treatment phase: Continuing sole PBS-subsidised supply for anticipated emergency treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 2 | # of repeats: 0 | DPMQ: $160.50 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
adrenaline (epinephrine) 1 in 1000 (1 mg/mL) injection, 5 x 1 mL ampoules
Manner of administration:Injection
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 5 | # of repeats: 0 | DPMQ: $21.43 | Max safety net: $0.00 | General Patient Charge: Nil |
| Available brands | |||||
| Link Medical Products Pty Ltd | |||||
adrenaline (epinephrine) 1 in 1000 (1 mg/mL) injection, 5 x 1 mL ampoules
Manner of administration:Injection
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 5 | # of repeats: 0 | DPMQ: $21.43 | Max safety net: $22.91 | General Patient Charge: $25.00 |
| Available brands | |||||
| Link Medical Products Pty Ltd | |||||
adrenaline (epinephrine) 150 microgram/0.3 mL injection, 0.3 mL pen device
Manner of administration:Injection
Restriction
Indication: Acute allergic reaction with anaphylaxis
Treatment phase: Initial sole PBS-subsidised supply for anticipated emergency treatment
Restriction
Indication: Acute allergic reaction with anaphylaxis
Treatment phase: Initial sole PBS-subsidised supply for anticipated emergency treatment
Restriction
Indication: Acute allergic reaction with anaphylaxis
Treatment phase: Continuing sole PBS-subsidised supply for anticipated emergency treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 2 | # of repeats: 0 | DPMQ: $160.50 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||
adrenaline (epinephrine) 300 microgram/0.3 mL injection, 0.3 mL pen device
Manner of administration:Injection
Restriction
Indication: Acute allergic reaction with anaphylaxis
Treatment phase: Initial sole PBS-subsidised supply for anticipated emergency treatment
Restriction
Indication: Acute allergic reaction with anaphylaxis
Treatment phase: Initial sole PBS-subsidised supply for anticipated emergency treatment
Restriction
Indication: Acute allergic reaction with anaphylaxis
Treatment phase: Continuing sole PBS-subsidised supply for anticipated emergency treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 2 | # of repeats: 0 | DPMQ: $160.50 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||
